aid: vialase name: ViaLase description: 'ViaLase, Inc. is a globally-minded, venture and strategic capital-backed, clinical stage medical technology company headquartered in Aliso Viejo, California, founded and led by Tibor Juhasz, PhD. The company develops the ViaLuxe Laser System, which combines femtosecond laser technology with micron-resolution OCT image guidance to perform femtosecond laser image-guided high-precision trabeculotomy (FLigHT) — a noninvasive, non-incisional procedure that creates drainage apertures through the trabecular meshwork to lower intraocular pressure in patients with open-angle glaucoma. The system pairs the ViaLuxe laser with the ViaLens patient interface and the ViaVue gonio camera. The company closed an approximately $40 million Series C financing in April 2024 with participation from Venture Investors Health Fund, Arboretum Ventures and Falcon Vision. The ViaLase Laser received CE Mark approval in the European Union in 2024 for adult patients with primary open-angle glaucoma and is under evaluation in a US IDE clinical trial; it is not approved for sale in the United States. ViaLase is a medical device manufacturer rather than a software vendor: it publishes no public API, developer portal, SDK, or machine-readable specification, and vialase.com is a WordPress marketing and clinical-education site.' image: https://www.vialase.com/wp-content/uploads/2024/07/vialase-social-image.png url: https://raw.githubusercontent.com/api-evangelist/vialase/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: profiled x-tier-reason: enrichment-pass-no-api-surface specificationVersion: '0.20' created: '2026-09-02' modified: '2026-09-02' tags: - Company - Medical Devices - Healthcare - MedTech - Ophthalmology - Glaucoma - Femtosecond Laser - Surgical Devices - Clinical Trials - Medical Imaging apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://www.vialase.com/ - type: Blog url: https://www.vialase.com/news/ - type: BlogRSS url: https://www.vialase.com/feed/ - type: PrivacyPolicy url: https://www.vialase.com/privacy-policy/ - type: LinkedIn url: https://www.linkedin.com/company/vialase/ - type: DomainSecurity url: security/vialase-domain-security.yml - type: LLMsTxt url: llms/vialase-llms.txt x-enrichment: date: '2026-09-02' status: minimal artifacts_added: 3 pass: local-v1 x-coverage: state: none reason: not-a-software-company detail: ViaLase manufactures a single clinical-stage ophthalmic capital device — the ViaLuxe femtosecond laser with its ViaLens patient interface and ViaVue gonio camera — whose only data connectivity is a Bluetooth-paired tablet at the bedside; vialase.com is an eleven-page WordPress marketing and clinical-education site with no api./developer./docs./status./portal./trust. hostname anywhere in DNS, and the only machine-readable JSON served on the domain is the stock WordPress core REST API at /wp-json/, which is CMS scaffolding rather than a product API. evidence: - url: https://www.vialase.com/openapi.json status: 404 - url: https://www.vialase.com/graphql status: 404 - url: https://www.vialase.com/llms.txt status: 404 - url: https://www.vialase.com/.well-known/agent-card.json status: 404 - url: https://www.vialase.com/.well-known/security.txt status: 404 - url: https://www.vialase.com/.well-known/api-catalog status: 404 - url: https://www.vialase.com/wp-json/ status: 200 - url: https://www.vialase.com/ status: 200 checked: '2026-09-02'